US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Completed

Irbesartan Tablets 300 mg 90 count Rx only Manufactured by…

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Prinston Pharmaceutical Inc NDC 43547-376-09 D-0409-2019
Class II · Moderate risk Terminated

Docusate Sodium

Reason Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.

Rx Pak Division of McKesson Corporation NDC 63739-0478-10 D-1007-2019
Class II · Moderate risk Terminated

Infants' Ibuprofen

Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Tris Pharma Inc. NDC 50428-1252-4 D-0495-2019
Class II · Moderate risk Terminated

infants* IBUPROFEN

Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Tris Pharma Inc. NDC 49035-125-24 D-0494-2019
Class II · Moderate risk Terminated

Infants' Ibuprofen

Reason Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Tris Pharma Inc. NDC 59779-925-23 D-0493-2019
Class II · Moderate risk Terminated

HEPERAIN 50 mg/50 mL

Reason Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)

Advanced Pharma Inc. D-0430-2019
Class II · Moderate risk Terminated

Fluocinolone Acetonide Topical Solution

Reason Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.

Lupin Somerset NDC 43386-069-60 D-0390-2019
Class II · Moderate risk Terminated

Ezetimibe and Simvastatin Tablets 10mg/80 mg

Reason Presence of Foreign Substance: Product complaint of black speckles observed on tablets.

Dr. Reddy's Laboratories, Inc. NDC 43598-586-10 D-0389-2019
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Major Pharmaceuticals NDC 0904-6390-61 D-1466-2019
Class II · Moderate risk Terminated

Lipoic Acid Injection

Reason Presence of Particulate Matter: filmy/cloudy particulate observed in vial.

McGuff Compounding Pharmacy Services, Inc. D-0802-2020
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension USP 250mg/5 mL

Reason CGMP Deviations; presence of extraneous material in the was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven bag) of sucrose (an excipient) used in the finished product.

Lupin Pharmaceuticals Inc. NDC 68180-441-01 D-0423-2019
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension USP

Reason CGMP Deviation; manufacturing batch record could not be located

Lupin Pharmaceuticals Inc. NDC 68180-0124-02 D-0380-2019
Class II · Moderate risk Terminated

Lidocaine gel 1%

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0408-2019
Class II · Moderate risk Terminated

Glutathione liquid

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0407-2019
Class II · Moderate risk Terminated

Cyclosporin liquid 0.05%

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0406-2019
Class II · Moderate risk Terminated

Cyclosporin liquid 0.2%

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0405-2019
Class II · Moderate risk Terminated

Cyclosporin liquid 0.5%

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0404-2019
Class II · Moderate risk Terminated

Cyclosporin liquid 1%

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0403-2019
Class II · Moderate risk Terminated

Vitamin B12 liquid 1000mcg/ml

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0402-2019
Class II · Moderate risk Terminated

Testosteron Cypionate liquid 200mg/ml

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0401-2019
Class II · Moderate risk Terminated

Methocarbamol liquid 100mg/ml

Reason Lack of sterility assurance.

Hiers Enterprises, LLC dba Northwest Compounding Pharmacy D-0400-2019